UniDoc Health Partners with Carefluence® to Enhance eHealth Interoperability

Seamless Integration to Elevate eHealth Solutions Across Healthcare IT Systems

VANCOUVER, British Columbia, September 17, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce a strategic partnership with Carefluence®, a recognized innovator in healthcare interoperability solutions. This collaboration will embed Carefluence’s advanced Fast Healthcare Interoperability Resources (“FHIR”)-based platform into UniDoc’s telehealth solutions, enabling seamless data exchange and connectivity across multiple health IT systems.

Key Features:

  • Partnership to embed FHIR-based interoperability directly into UniDoc’s telehealth solutions.
  • Enables UniDoc’s platform to broadly interface with electronic health records (“EHRs”), health information systems (“HISs”), and other digital health platforms.
  • Enhances care continuity, coordination, and patient safety through seamless data exchange.

 

“The integration of Carefluence’s interoperability platform into our eHealth solutions is an important advancement for UniDoc,” said Antonio Baldassarre, CEO of UniDoc Health Corp. “Many health IT systems come with their own APIs and cloud systems, leading to fragmented patient health. This partnership will allow our H3 Health Cube to bridge the gaps between disparate health monitoring devices, central healthcare systems, EHRs, and billing systems, delivering a unified view of patient health.

Additionally, by ensuring that our customers can continue using their existing systems, we are not only speeding up the integration process but also reducing overall costs for our clients. This is a strong addition to our platform, further solidifying UniDoc’s position in the eHealth market.”

Through this partnership, Carefluence will deliver its Office of the National Coordinator for Health Information Technology (“ONC”)-certified, FHIR-based OpenAPI and a comprehensive suite of interoperability tools to UniDoc’s eHealth solutions. This integration will facilitate interoperability between UniDoc’s device data platform and multiple health information systems, including EHRs, HISs, and other digital health platforms. This initiative is poised to enhance continuity of care, improve care coordination, and help to ensure patient safety across the healthcare continuum.

Carefluence’s platform is designed to eliminate technological barriers, enabling smooth communication between disparate systems within healthcare communities. The platform helps healthcare providers save time and costs associated with data portability and workflow integration, making it an asset in the increasingly digital healthcare landscape.

“With real-world experience over the past decade in implementing interoperability solutions, Carefluence has the Fast Healthcare Interoperability Resources ability to adapt to the needs of its customers with creativity and technology,” said Dr. Suresh Anne, President of Carefluence. “We are excited about our partnership with UniDoc Health and look forward to applying our solutions to the benefit of UniDoc’s customers.”

In addition, further to the Company’s news release on May 21, 2024, the Company has exercised its option to extend its engagement with Rumble Strip Media Inc. (“Rumble”) to provide certain social media, marketing, and consulting services to UniDoc (the “Services”) for an additional period of three months beginning on September 17, 2024. The Services may include investor relations activities within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with the extension, the Company has agreed to pay Rumble an additional US$500,000 plus applicable taxes. Rumble and its principals are arm’s length to the Company and, to the knowledge of the Company, Rumble do not own, control, or direct any securities of the Company. Rumble Strip Media Inc. (Address: #893 250-997 Seymour St, Vancouver, British Columbia, V6B 3M1; Email: info@rumblestrip.ca) is a Vancouver-based media and consulting firm.

The Company is also pleased to announce that it has received total proceeds of approximately $1,632,330 from the exercise of share purchase warrants since June 28, 2024. The warrants were issued in connection with a private placement completed on March 31, 2021.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

About Carefluence

Carefluence® revolutionizes interoperability by developing cohesive, FHIR-based healthcare data and workflow connectivity. The Carefluence® platform facilitates standards-based data exchange across health IT systems, ensuring continuity of care, efficient care coordination, and enhanced patient safety. As the first interoperability platform in the U.S. to achieve ONC certification for its FHIR-based OpenAPI, Carefluence remains a leader in pioneering and deploying advanced interoperability solutions.

For further information, please contact:

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Forward-Looking Statements

This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the capabilities of the Carefluence technology, the integration of Carefluence technology into the Company’s products, and the services to be provided by Rumble and the timing thereof.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company’s annual management discussion and analysis dated July 31, 2024 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information.

Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising new companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. Mr. Thornberry has split his time working in Toronto, Ont., and Vancouver, B.C. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Sina Pirooz

Director

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels.

Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value.

Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Franco Staino

DIRECTOR

Mr. Franco Staino is a business professional with over 40 years experience in the pharmaceutical industry. Mr. Staino has significant experience in drug safety, traceability and anti-counterfeiting measures and has designed and implemented programs for the Italy National Health Service, the Ministry of Health and the Polygraphic Institute and State Mint.

Mr. Staino currently holds multiple positions including being the control representative of Carlucci a leading company engaged in the production of self-adhesive labels for consumer goods with high specialization for the pharmaceutical sector, and President of the Board of Directors of Topharmacia, a company that deals with the integral management of pharmacies throughout Italy in order to improve their ability to provide social and commercial services, to connect industrial marketing policy to that of the pharmacy, to offer tools in able to guarantee the financial balance of the companies involved.